Expanding the role of small-molecule PSMA ligands beyond PET staging of prostate cancer

Nature Reviews Urology, Published online: 14 January 2020; doi:10.1038/s41585-019-0272-5In this Review, Siva and colleagues discuss the uses of (PSMA)–positron emission tomography (PET) beyond its role in conventional prostate cancer imaging. PSMA could have utility in other genitourinary malignancies and oligometastatic prostate cancer, theranostics, selection and guidance of radiotherapy fields, as well as the assessment of response to treatment.

Source: Nature Reviews Urology - January 13, 2020 Category: Urology & Nephrology Authors: Shankar Siva Cristian Udovicich Ben Tran Homi Zargar Declan G. Murphy Michael S. Hofman Source Type: research